Gå direkt till huvudinnehållet

Estetisk medicin

Senast uppdaterad: Publicerad:

  1. Carruthers JD, Glogau RG, Blitzer A, for the Facial Aesthetics Consensus Group Faculty. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies—consensus recommendations. Plast Reconstr Surg 2008; 121(5 suppl): 5S–36S.
  2. Fedok FG. Advances in minimally invasive facial rejuvenation. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 359-68. PubMed  
  3. de Maio M. The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg 2004; 28: 295-300. PubMed  
  4. Sommer B, Zschocke I, Bergfeld D, Sattler G, Augustin M. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol Surg 2003; 29: 456-60. PubMed  
  5. Sadick NS. A structural approach to nonablative rejuvenation. Cosmet Dermatol 2002; 15: 39-43. PubMed  
  6. Zimbler MS, Kokoska MS, Thomas JR. Anatomy and pathophysiology of facial aging. Facial Plast Surg Clin North Am 2001; 9: 179-87. PubMed  
  7. Training guidelines for the use of botulinum toxin for the treatment of neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1994; 44: 2401-3. Neurology  
  8. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001; 323: 596-9. British Medical Journal  
  9. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the Botox Migraine Clinical Research Group. Headache 2000; 40: 445-50. PubMed  
  10. Carruthers J, Carruthers A. The use of botulinum toxin type A in the upper face. Facial Plast Surg Clin North Am 2006; 14: 253-60. PubMed  
  11. Maas CS. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face. Facial Plast Surg Clin North Am 2006; 14: 241-5. PubMed  
  12. Carruthers J, Fagien S, Matarasso SL, for the Botox Consensus Group. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 2004; 114(6 suppl): 1S-22S.
  13. Wise JB, Greco T. Injectable treatments for the aging face. Facial Plast Surg 2006; 22: 140-6. PubMed  
  14. Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol 2006; 17: 471-9. PubMed  
  15. Eppley BL, Dadvand B. Injectable soft-tissue fillers: clinical overview. Plast Reconstr Surg 2006; 118: 98e-106e.
  16. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging 2007; 2: 369-76. PubMed  
  17. Born T. Hyaluronic acids. Clin Plast Surg 2006; 33: 525-38. PubMed  
  18. Niamtu J III. Facial aging and regional enhancement with injectable fillers. Cosmet Dermatol 2007; 20(5 suppl 2): 14-20.
  19. Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC III. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg 2008; 121: 289-97. PubMed  
  20. Sarkar P, Hirsch RJ. Update on laser hair removal. Cosmet Dermatol 2007; 20: 440-4. PubMed  
  21. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341: 491-7. New England Journal of Medicine  
  22. Haedersdal M, Götzsche PC. Laser and photoepilation for unwanted hair growth. Cochrane Database Syst Rev, issue 4, 2006. CD004684. Cochrane (DOI)  
  23. Haedersdal M, Wulf HC. Evidence-based review of hair removal using laser and light sources. J Eur Acad Dermatol Venereol 2006; 20: 9-20. PubMed  
  24. Altshuler GB, Anderson RR, Manstein D, Zenzie HH, Smirnov MZ. Extended theory of selective photothermolysis. Lasers Surg Med 2001; 29: 416-32. PubMed  
  25. Klavuhn KG, Green D. Importance of cutaneous cooling during photo-thermal epilation: theoretical and practical considerations. Lasers Surg Med 2002; 31: 97-105. PubMed  
  26. Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed 2000; 16: 239-44. PubMed  
  27. Ross EV, Smirnov M, Pankratov M, Altshuler G. Intense pulsed light and laser treatment of facial telangiectasias and dyspigmentation: some theoretical and practical comparisons. Dermatol Surg 2005; 31: 1188-98. PubMed  
  28. Weiss RA, Weiss MA, Beasley KL. Rejuvenation of photoaged skin: 5 years results with intense pulsed light of the face, neck, and chest. Dermatol Surg 2002; 28: 1115-9. PubMed  
  29. Adamic M, Troilius A, Adatto M, Drosner M, Dahmane R. Vascular lasers and IPLS: guidelines for care from the European Society for Laser Dermatology (ESLD). J Cosmet Laser Ther 2007; 9: 113-24. PubMed  
  30. Fabbrocini G. Chemical peels. eMedicine, accessed November 11, 2009. emedicine.medscape.com  
  31. Coimbra M, Rohrich RJ, Chao J, Brown SA. A prospective controlled assessment of microdermabrasion for damaged skin and fine rhytides. Plast Reconstr Surg 2004; 113: 1438-43. PubMed  
  32. Shim EK, Barnette D, Hughes K, Greenway HT. Microdermabrasion: a clinical and histopathologic study. Dermatol Surg 2001; 27: 524-30. PubMed  
  33. Grimes PE. Microdermabrasion. Dermatol Surg 2005; 31: 1160-5. PubMed  
  34. Kessler E, Flanagan K, Chia C, Rogers C, Glaser DA. Comparison of alpha-and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg 2008; 34: 45-50. PubMed  
  35. Sadick NS, Finn N. A review of microdermabrasion. Cosmet Dermatol 2005; 18: 351-4. PubMed  
  36. Tung RC, Bergfeld WF, Vidimos AT, Remzi BK. Alpha-hydroxy acid-based cosmetic procedures. Guidelines for patient management. Am J Clin Dermatol 2000; 1: 81-8. PubMed  
  37. Kligman D. Technologies for cutaneous exfoliation using salicylic acid. Dermatol Ther 2001; 14: 225-7. PubMed  
  • Ulf Samuelson, docent och specialist i plastikkirurgi, Akademikliniken, Stockholm

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim